Package 67296-2198-5

{"route": ["ORAL"], "spl_id": "45d24733-842b-7795-e063-6294a90ae919", "openfda": {"nui": ["N0000175462", "M0015066", "N0000009947"], "upc": ["0331722560306"], "unii": ["G70B4ETF4S", "OTT9J7900I"], "rxcui": ["476556"], "spl_set_id": ["44f2503d-7863-61a8-e063-6394a90a83c4"], "pharm_class_cs": ["Nucleosides [CS]"], "pharm_class_epc": ["Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]"], "pharm_class_moa": ["Nucleoside Reverse Transcriptase Inhibitors [MoA]"], "manufacturer_name": ["Redpharm Drug"]}, "finished": true, "packaging": [{"sample": false, "description": "3 TABLET, FILM COATED in 1 BOTTLE (67296-2198-3)", "package_ndc": "67296-2198-3", "marketing_start_date": "20211007"}, {"sample": false, "description": "5 TABLET, FILM COATED in 1 BOTTLE (67296-2198-5)", "package_ndc": "67296-2198-5", "marketing_start_date": "20211007"}], "brand_name": "Emtricitabine and tenofovir disoproxil fumarate", "product_id": "67296-2198_45d24733-842b-7795-e063-6294a90ae919", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]", "Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]", "Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]", "Nucleoside Reverse Transcriptase Inhibitors [MoA]", "Nucleoside Reverse Transcriptase Inhibitors [MoA]", "Nucleosides [CS]", "Nucleosides [CS]"], "product_ndc": "67296-2198", "generic_name": "Emtricitabine and tenofovir disoproxil fumarate", "labeler_name": "Redpharm Drug", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Emtricitabine and tenofovir disoproxil fumarate", "active_ingredients": [{"name": "EMTRICITABINE", "strength": "200 mg/1"}, {"name": "TENOFOVIR DISOPROXIL FUMARATE", "strength": "300 mg/1"}], "application_number": "ANDA201806", "marketing_category": "ANDA", "marketing_start_date": "20211007", "listing_expiration_date": "20261231"}